Product Image

Contributor Information

  • Institute University of Cambridge
  • Primary citation Tommasino et al. 1993. Oncogene. 8(1):195-202. PMID: 8380917.

Tool Details

  • Tool name: Anti-HPV16E7 [TVG 701Y] mAb
  • Alternate names: Anti-Human Papillomavirus 16 (E7) antibody [TVG 701Y]; Anti-HPV16E7 [TVG 701Y]; HPV16 E7; Protein E7; E7; HPV antibody
  • Clone: TVG 701Y
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Human papilloma virus
  • Host: Mouse
  • Cancer type: Gynaecologic cancer
  • Application: ELISA ; FACS ; IHC ; IF ; WB
  • Strain: Balb/c
  • Description: Tumour antigens are proteins found in tumour cells and recognised by cellular or humoral effectors of the immune system. Tumour antigens are useful in identifying cancer cells, they also can be leveraged as targets in cancer therapy.

    Anti-Human Papillomavirus 16 (E7) antibody [TVG 701Y] also known as Anti-HPV16E7 [TVG 701Y] is an antibody against a tumour-specific antigen (TSA). TSA's are restricted to tumours and are not found in healthy cells. Anti-HPV16E7 [TVG 701Y] is a monoclonal antibody against HPV16E7.

    The human papilloma virus (HPV) family of DNA tumour viruses includes HPV-16 and HPV-18. These are associated with a large proportion of cervical cancer cases. E7 is the major transforming protein of human papillomavirus type 16 (HPV16).

    The immunogen is HPV 16 E7 synthesised from S. pombe.
  • Immunogen: HPV 16 E7 synthesised from S. pombe
  • Isotype: IgG2a
  • Research area: Cancer; Microbiology
  • Myeloma used: P3/NS1/1-Ag4.1

  • For Research Use Only

Target Details

  • Target: Human Papilloma Virus-16 early protein 7 (HPV16 E7)
  • Target background: The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases. HPV early proteins E6 and E7 are the major viral oncoproteins that regulate cell proliferation through the inactivation of p53 and Rb1 tumour suppressor proteins respectively.

Application Details

  • Application: ELISA ; FACS ; IHC ; IF ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15°C to -25°C
  • Shipping conditions: Shipping at 4°C

Documentation

References

  •   Chen et al. 2020. Antiviral Res. 178:104794. PMID: 32298665.
  •   Kannan et al. 2017. Sci Rep. 7:46102. PMID: 28383029.
  •   Harris et al. 2013. Br J Cancer. 108(4):859-865. PMID: 23385729.
  •   Tommasino et al. 1993. Oncogene. 8(1):195-202. PMID: 8380917.